Back
Axsome Therapeutics Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
AXSM
Axsome Therapeutics
Last Price:
$118.50
Seasonality Move:
19.74%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bearish and AXSM is experiencing selling pressure, which indicates risk of future bearish movement.
Axsome Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 123.49 | Sell |
| 20-day SMA: | 123.64 | Sell |
| 50-day SMA: | 117.5 | Buy |
| 200-day SMA: | 95.28 | Buy |
| 8-day EMA: | 122.09 | Sell |
| 20-day EMA: | 122.82 | Sell |
| 50-day EMA: | 117.2 | Buy |
| 200-day EMA: | 98.97 | Buy |
Axsome Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.62 | Buy |
| Relative Strength Index (14 RSI): | 44.34 | Sell |
| Chaikin Money Flow: | -342463 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.72 - 129.02) | Sell |
| Bollinger Bands (100): | (88.92 - 120.8) | Buy |
Axsome Therapeutics Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Axsome Therapeutics Stock
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 118.53 while AXSM 8-day simple moving average is 123.49, which is a Sell signal.
-
The stock price of AXSM is 118.53 while Axsome Therapeutics 20-day SMA is 123.64, which makes it a Sell.
-
Axsome Therapeutics 50-day simple moving average is 117.50 while AXSM share price is 118.53, making it a Buy technically.
-
AXSM stock price is 118.53 and Axsome Therapeutics 200-day simple moving average is 95.28, creating a Buy signal.
AXSM Technical Analysis vs Fundamental Analysis
Sell
47
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy or a Sell?
-
Axsome Therapeutics stock is rated a SellThe current Axsome Therapeutics [AXSM] share price is $118.53. The Score for AXSM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Axsome Therapeutics Stock Info
Market Cap:
5.8B
Price in USD:
118.53
Share Volume:
435.3K
Axsome Therapeutics 52-Week Range
52-Week High:
139.13
52-Week Low:
64.11
Sell
47
Axsome Therapeutics (AXSM)
is a Sell
Axsome Therapeutics Share Price Forecast
-
What is the Axsome Therapeutics stock price today?The Axsome Therapeutics stock price is 118.53 USD today.
-
Will AXSM stock go up or go down?Axsome Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Axsome Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Axsome Therapeutics is overvalued.
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 118.53 while AXSM 8-day exponential moving average is 122.09, which is a Sell signal.
-
The stock price of AXSM is 118.53 while Axsome Therapeutics 20-day EMA is 122.82, which makes it a Sell.
-
Axsome Therapeutics 50-day exponential moving average is 117.20 while AXSM share price is 118.53, making it a Buy technically.
-
AXSM stock price is 118.53 and Axsome Therapeutics 200-day simple moving average is 98.97, creating a Buy signal.
Fundamental Analysis of Axsome Therapeutics
Is Axsome Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.59 per share, an increase next quarter of $0.25 per share, an increase this year of $1.54 per share, and an increase next year of $5.14 per share.
Technical Analysis of Axsome Therapeutics
Should I short Axsome Therapeutics stock?
-
AXSM Moving Average Covergence Divergence (MACD) indicator is 0.62, suggesting Axsome Therapeutics is a Buy
-
Axsome Therapeutics Relative Strength Index (RSI) is 44.34, which suggest Axsome Therapeutics is oversold
-
The Bollinger Bands (25) for Axsome Therapeutics is (120.72 - 129.02), which suggest Axsome Therapeutics is a Buy
-
The Bollinger Bands (100) for Axsome Therapeutics is (88.92 - 120.8), which suggest Axsome Therapeutics is a Buy
* Axsome Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.